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In “Chip Making’s Singular Future” an IEEE
feature, authored by Rajendra Singh,
Clemson University, and Randhir Thakur,
Applied Materials Inc, the abstract notes
that, for years, IC chip makers have been 
in love with “bigger” and “more”-- bigger
wafers, holding more chips, then manu-
facturing the wafers in batches to yield
still more chips. [While praying for a 70%
yield rate.] 
It has been a process that allowed the 
silicon industry to achieve Moore’s Law. It
has been responsible for dropping chip
and device prices into the basest of 
commodities.
Of course the development has always
needed equipment makers like Applied
Materials to be prepared, at a price, to
cater to the ‘bigger’ equipped fab’s needs. 
Now, apparently, according to the authors,
(and they should know with one of them
coming from Applied Materials): “Alas,
this love affair is over, for chip makers
have learned that their push for more can
quickly lead to a glut of chips, especially
during the turbulent times of the last few
years.”
Well, compound facilities and foundries
too are well aware of the value of the 
single wafer approach, and the content-
ment that can often be had at 2,” 3,” 
4,” 5” and even the vast fields of 6”
wafers. 
But even there, turbulent times can indeed
be as devastating as any glut.
“The favored approach in silicon now
(apparently) is to put a brake to all that
chip making. Instead, at an increasing
number of fabrication houses, production
equipment is turning out just a single
wafer at a time.”
[Single wafers are of course now a “new”
equipment supplier revenue market and
many of the latest launches have been for
this new age, single wafer.].
“Done properly,” notes the abstract,
“such single-wafer manufacturing not
only leads to lower inventories, but to
lower costs, faster throughput and time
to market.”
What intrigues me in all this is that
nowhere is any mention made of the
issue of yield. It’s a small, quaint word
that goes along with quality and it’s rare
that a fab will confess its yield rates.
Gossip has it, that yield is often below
70%, putting fabs among industry’s lower
performers in terms of manufacturing
yield. 
In fairness to the article authors, perhaps
what’s termed “done properly” explores
the yield issue. 
But I still have my fingers crossed to 
find even single wafer yield rates in 
silicon or compound, at any size of wafer,
that are comfortably in the high 90’s for
yield.
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